Mossman, David
Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists. [electronic resource]
- BMC cancer Jul 2010
- 366 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 1471-2407
Standard No.: 10.1186/1471-2407-10-366 doi
Subjects--Topical Terms: Acetylation Apoptosis Azacitidine--analogs & derivatives Biomarkers, Tumor--genetics Blotting, Western Cell Proliferation Cells, Cultured Colorectal Neoplasms--drug therapy CpG Islands DNA Methylation DNA Modification Methylases--antagonists & inhibitors DNA, Neoplasm--genetics Decitabine Enzyme Inhibitors--pharmacology Epigenesis, Genetic Fibroblasts--cytology Gene Expression Profiling Gene Expression Regulation, Neoplastic--drug effects Genome, Human Histone Deacetylase Inhibitors--pharmacology Histone Deacetylases--chemistry Histones--metabolism Humans Hydroxamic Acids--pharmacology Immunoenzyme Techniques Oligonucleotide Array Sequence Analysis Promoter Regions, Genetic--genetics RNA, Messenger--genetics Reverse Transcriptase Polymerase Chain Reaction